HMGB1 and Miyoshi myopathy: Similarly, TLR4 inhibition via siRNA or TAK-242 reduced the S-phase population and increased apoptosis (Figure S5), with TLR4 silencing also downregulating HMGB1 expression (Figure S2), highlighting a regulatory link between TLR4 and HMGB1 in MM cell survival.